Why a key vaccine advisory panel is full of vacancies

The group known as ACIP appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country.

February 8, 2024 Check out STAT+

Sponsored By

Adobe STAT+ | HHS leaves vacant more than half the slots on a key vaccine advisory panel ACIP, normally a 15-member panel, has eight vacancies, and four more coming soon. Why hasn't HHS signed off on the CDC's nominees? By Helen Branswell In a showy hearing, Bernie Sanders gets few answers about lower drug prices In a jam-packed hearing room, Sen. Bernie Sanders pressed CEOs with familiar questions about how expensive drugs are in America. By Rachel Cohrs Higher naloxone doses have no impact on overdose survival, study shows New study shows higher doses of naloxone, commonly known by the brand Narcan, aren't necessarily more effective at reversing opioid overdoses. By Lev Facher Kent Nishimura/Getty Images STAT+ | Senate Democrats push for stronger rules around AI in Medicare Advantage Senate Democrats wants Medicare to take more aggressive action to prevent health insurance companies from using AI to deny medical services. By Bob Herman and Casey Ross STAT+ | As Medicare drug pricing negotiations begin, AstraZeneca stays mum on government's offer The company wouldn't disclose details about Medicare's initial offer as negotiations over the price of some drugs began. By Andrew Joseph STAT+ | A looming cancer vaccine test for Gritstone Bio, and pushback about Novartis-MorphoSys Adam Feuerstein previews the expected readout from Gritstone Bio's neoantigen cancer vaccine study, and discusses the Novartis-MorphoSys deal. By Adam Feuerstein Listen: AI in medicine, detangling hype, and Icelandic DNA STAT's Casey Ross explains how researchers and pharma are using AI to find new drug targets, design therapies, and improve clinical trials. By Damian Garde and Allison DeAngelis and Adam Feuerstein Could testosterone be a useful treatment for menopause? Testosterone is sometimes prescribed to relieve menopause symptoms, but there's a lack of research on the hormone's effects on women. By Annalisa Merelli

More around STAT

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Daily Recap? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2024, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser